Praxis Precision Medicines (PRAX) Retained Earnings: 2022-2025
Historic Retained Earnings for Praxis Precision Medicines (PRAX) over the last 4 years, with Sep 2025 value amounting to -$1.1 billion.
- Praxis Precision Medicines' Retained Earnings fell 41.37% to -$1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 billion, marking a year-over-year decrease of 41.37%. This contributed to the annual value of -$836.7 million for FY2024, which is 27.96% down from last year.
- According to the latest figures from Q3 2025, Praxis Precision Medicines' Retained Earnings is -$1.1 billion, which was down 12.57% from -$977.2 million recorded in Q2 2025.
- In the past 5 years, Praxis Precision Medicines' Retained Earnings registered a high of -$385.3 million during Q1 2022, and its lowest value of -$1.1 billion during Q3 2025.
- For the 3-year period, Praxis Precision Medicines' Retained Earnings averaged around -$769.9 million, with its median value being -$726.2 million (2024).
- Data for Praxis Precision Medicines' Retained Earnings shows a maximum YoY crashed of 47.43% (in 2023) over the last 5 years.
- Praxis Precision Medicines' Retained Earnings (Quarterly) stood at -$530.6 million in 2022, then declined by 23.23% to -$653.9 million in 2023, then declined by 27.96% to -$836.7 million in 2024, then plummeted by 41.37% to -$1.1 billion in 2025.
- Its Retained Earnings was -$1.1 billion in Q3 2025, compared to -$977.2 million in Q2 2025 and -$906.0 million in Q1 2025.